SynthesisFrontiers in oncology2020

Efficacy and Safety of PD-1/PD-L1 Inhibitors Plus Chemotherapy Versus PD-1/PD-L1 Inhibitors in Advanced Non-Small Cell Lung Cancer: A Network Analysis of Randomized Controlled Trials.

Xiang Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.